In conclusion, the combination of TA and cisplatin significantly promotes lung cancer cell apoptosis, and one of the synergistic antitumor mechanisms is mediated via the PERK-ATF4-CHOP pathway. Here, EIF2AK3 is linked to lung carcinoma.